HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fulton, D. Articles by Quilley, J. Search for Related Content PubMed PubMed Citation Articles by Fulton, D. Articles by Quilley, J. Social Bookmarking                      What's this?

The Journal of Lipid Research, Vol. 39, 1713-1721, August 1998
Copyright © 1998 by Lipid Research, Inc.

Original Article

A method for the determination of 5,6-EET using the lactone as an intermediate in the formation of the diol

Correspondence to: J. Quilley.

The 5,6 epoxyeicosatrienoic acid (5,6-EET) exhibits a range of biological activities but the functional significance of this labile eicosanoid is unknown due, in part, to difficulties of quantitation in biological samples. We have developed a sensitive and specific method to measure 5,6-EET utilizing its selective capacity to form a lactone. The initial conversion of 5,6-EET and 5,6-dihydroxyeicosatrienoic acid (5,6-DHT) to 5,6--lactone is followed by selective purification using reverse phase high performance liquid chromatography (HPLC), reconversion to 5,6-DHT and quantitation by gas chromatography-mass spectrometry (GCMS). In oxygenated Krebs' buffer, 5,6-EET degrades to 5,6--lactone and 5,6-DHT with a t_1/2 8 min. In the presence of camphorsulfonic acid, 5,6-EET and 5,6-DHT convert to a single HPLC peak ( = 205) comigrating with 5,6--lactone. Incubation of 5,6--lactone with triethylamine resulted in a single HPLC peak with the retention time of 5,6-DHT. In the perfusate from the isolated kidney, release of 5,6-EET (20 ± 5 pg/ml), measured indirectly via conversion to 5,6-DHT, was approx. 6-fold less than that reported for prostaglandin E₂ (PGE₂) and 20-HETE. The coronary perfusate concentration of 5,6 EET was 9 ± 2 pg/ml. 5,6-EET recovered from renal and coronary perfusates was increased 2-fold to 45.5 ± 5.5 pg/ml and 21.6 ± 6.3 pg/ml, respectively, by arachidonic acid.—Fulton, D., J. R. Falck, J. C. McGiff, M. A. Carroll, and J. Quilley. A method for the determination of 5,6-EET using the lactone as an intermediate in the formation of the diol. J. Lipid Res. 1998. 39: 1713–1721.

Supplementary key words: 5,6-EET, 5,6-DHT, 5,6--lactone, GC–MS, heart, kidney

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. M. Nusing, H. Schweer, I. Fleming, D. C. Zeldin, and M. Wegmann Epoxyeicosatrienoic acids affect electrolyte transport in renal tubular epithelial cells: dependence on cyclooxygenase and cell polarity Am J Physiol Renal Physiol, July 1, 2007; 293(1): F288 - F298. [Abstract] [Full Text] [PDF]

				D. I. Draganov, J. F. Teiber, A. Speelman, Y. Osawa, R. Sunahara, and B. N. La Du Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities J. Lipid Res., June 1, 2005; 46(6): 1239 - 1247. [Abstract] [Full Text] [PDF]

				W. Yang, K. M. Gauthier, L. M. Reddy, B. Sangras, K. K. Sharma, K. Nithipatikom, J. R. Falck, and W. B. Campbell Stable 5,6-Epoxyeicosatrienoic Acid Analog Relaxes Coronary Arteries Through Potassium Channel Activation Hypertension, April 1, 2005; 45(4): 681 - 686. [Abstract] [Full Text] [PDF]

				H. Jiang, J. C. McGiff, J. Quilley, D. Sacerdoti, L. M. Reddy, J. R. Falck, F. Zhang, K. M. Lerea, and P. Y-K Wong Identification of 5,6-trans-Epoxyeicosatrienoic Acid in the Phospholipids of Red Blood Cells J. Biol. Chem., August 27, 2004; 279(35): 36412 - 36418. [Abstract] [Full Text] [PDF]

				S. I. Pomposiello, J. Quilley, M. A. Carroll, J. R. Falck, and J. C. McGiff 5,6-Epoxyeicosatrienoic Acid Mediates the Enhanced Renal Vasodilation to Arachidonic Acid in the SHR Hypertension, October 1, 2003; 42(4): 548 - 554. [Abstract] [Full Text] [PDF]

				J. R. Falck, U. M. Krishna, Y. K. Reddy, P. S. Kumar, K. M. Reddy, S. B. Hittner, C. Deeter, K. K. Sharma, K. M. Gauthier, and W. B. Campbell Comparison of vasodilatory properties of 14,15-EET analogs: structural requirements for dilation Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H337 - H349. [Abstract] [Full Text] [PDF]

				A. Yaghi, C. D. Webb, J. A. Scott, S. Mehta, J. R. Bend, and D. G. McCormack Cytochrome P450 Metabolites of Arachidonic Acid but Not Cyclooxygenase-2 Metabolites Contribute to the Pulmonary Vascular Hyporeactivity in Rats with Acute Pseudomonas Pneumonia J. Pharmacol. Exp. Ther., April 12, 2001; 297(2): 479 - 488. [Abstract] [Full Text]

				K. Nithipatikom, P. F. Pratt, and W. B. Campbell Determination of EETs using microbore liquid chromatography with fluorescence detection Am J Physiol Heart Circ Physiol, August 1, 2000; 279(2): H857 - H862. [Abstract] [Full Text] [PDF]